News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Miravant (MRVT) Announces Third Quarter Results For 2004



10/19/2005 5:12:13 PM

Miravant Medical Technologies (OTCBB:MRVT), a pharmaceutical development company specializing in PhotoPoint(R) photodynamic therapy (PDT), announced consolidated financial results for the third quarter ended September 30, 2004. The net loss for the quarter was $3.4 million or ($0.10) per diluted share, compared to a net income of $1.2 million, or $0.01 per diluted share, for the same period in 2003. The net loss for the nine months ended September 30, 2004, was $12.6 million or ($0.40) per diluted share, compared to a net loss of $5.9 million or ($0.24) per diluted share for the same period in 2003. The results for the three and nine month periods ended September 30, 2003, included a gain of $9.1 million the Company recorded for the settlement of its debt to Pharmacia.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES